Dr. Matthew L. Springer received his BA from the University of California, Berkeley in 1985 and his Ph.D. from Stanford University in 1992. He did postdoctoral research at Stanford and continued his research there as a senior scientist until joining the UCSF faculty in 2003, where he is currently one of two non-clinicians on the faculty of the Division of Cardiology. The close juxtaposition of his basic research background with the clinical cardiologists in the Division has resulted in an active translational research program.
Dr. Springer's research interests include cell therapy and gene therapy approaches to studying cardiovascular disease, with the goals of exploring potential treatments and understanding underlying mechanisms involved in angiogenesis, vascular function, and treatments for myocardial infarction. Further interests involve mechanisms underlying vascular reactivity and how they are affected by cigarette smoke exposure.
For more details about research and collaborators, please see the lab research interests page.
Cardiology Division Faculty Spotlight, August 2016
View a 2013 talk at the UCSF Center for Tobacco Control Research and Education "It's About a Billion Lives" symposium for the general public about our studies of how tobacco secondhand smoke impairs vascular endothelial function (let it load and then move the slider to time 1:36:45; it is about 25 minutes long)
View a 2005 talk in Geneva about ultrasound-guided injections into mouse myocardium
Neurospora photomicrograph resource links
(an online resource derived from Dr. Springer's graduate work)
The Earthquake Home Preparedness website, a companion resource to my campus and public seminars on this topic. You can also see streaming video of this talk here.
The fun part:
The "alternative" articles (front pages only):
Now you can listen to The Myoblast Song and read its lyrics.
Also check out The Myoblast Song 2.0
If you encounter any trouble with this website, please e-mail Matt Springer